Log In
BCIQ
Print this Print this
 

Leica Bond Oracle HER2 IHC System

  Manage Alerts
Collapse Summary General Information
Company Leica Microsystems GmbH
DescriptionImmunohistochemical (IHC) assay to determine HER2 status
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationCancer, Diagnostic
Indication DetailsDetermine HER2 oncoprotein status in formalin-fixed, parrafin embedded breast cancer tissue
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today